🇺🇸 FDA
Patent

US 7700651

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

granted A61KA61K31/606A61K9/127

Quick answer

US patent 7700651 (Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease) held by The Board of Regents of the University of Texas System expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/606, A61K9/127, A61P, A61P1/00